Patent · US Active

Use of Belinostat or pharmaceutically acceptable salt thereof in preparation of drug for treating infection

US11826325B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignees

HUAWEI CLOUD COMPUTING TECHNOLOGIES CO., LTD. · CN
The First Affiliated Hospital of Xi'an Jiaotong University · CN

Inventors

Bing Liu · Nanhu, CN
Denghui Liu · Lo Wu, CN
Xin Wang · Shanghai, CN
Peipei Zhang · Hangzhou City, CN
Yawen Wang · Xi'an, CN
Chi Xu · Beijing, CN
Nan Qiao · Beijing, CN

Key dates

Filing date	Jul 8, 2022
Grant date	Nov 28, 2023
Priority date	—
Expiry date	Jul 8, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is the use of Belinostat or a pharmaceutically acceptable salt thereof in preparation of a drug for treating an infection. Also disclosed are related methods and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.